🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The relation between improvement in results of treating spontaneous intrace...
Status
Completed
Location
Pomeranian Medical University
Start Date
2017-03-17
Trial ID
NCT06094244
Treatments Being Tested
This phase will commence following dose escalation in the 24mg bid group du...
Status
Recruiting
Location
The First Affilliated Hospital of Bengbu Medical University
Start Date
2025-01-28
Trial ID
NCT06754891
Treatments Being Tested
This Phase Ib/IIa study is evaluating the safety, tolerability, pharmacokin...
Status
Recruiting
Location
Cancer Hospital Chinese Academy of Medical Sciences
Start Date
2026-01-29
Trial ID
NCT07208149
Treatments Being Tested
A Phase Ia/Ib open label，clinical study evaluating the safety, tolerability...
Status
Recruiting
Location
Tianjin Cancer Hospital
Start Date
2023-06-29
Trial ID
NCT05868876
Treatments Being Tested
This is a follow-up study to assess safety and clinical activity of continu...
Status
Completed
Location
Studienzentrum der PROSENEX, AmbulatoriumsbetriebsgesmbH an der Confraternität-Privatklinik Josefstadt
Start Date
2016-02-02
Trial ID
NCT02618941
Treatments Being Tested
This is an open label, multicenter, dose escalation, phase Ib study to dete...
Status
Completed
Location
Institut Jules Bordet
Start Date
2016-10
Trial ID
NCT02741388
Treatments Being Tested
The purpose of this study is to see the safety and activity of using pasire...
Status
Completed
Location
Emory University Winship Cancer Institute
Start Date
2011-12
Trial ID
NCT01469572
Treatments Being Tested
AL2846 is a multi-target receptor tyrosine kinase inhibitor. The purpose of...
Status
Terminated
Location
Shanghai Ninth People's Hospital, School of Medicine, Shanghai JiaoTong University
Start Date
2021-09-07
Trial ID
NCT05011019
Treatments Being Tested
A Dose Finding Study of \[177Lu\]Lu-DOTA-TATE in Newly Diagnosed Glioblasto...
Status
Active Not Recruiting
Location
Col Uni Med Center New York Presby
Start Date
2022-05-10
Trial ID
NCT05109728
Treatments Being Tested
The objective of this extension study is the initial assessment of safety a...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-03-29
Trial ID
NCT02690181
Treatments Being Tested